News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Sapphiros Taps Teresa Abraham for VP of Scientific and Technical Affairs

READ MORE

Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO

READ MORE

Sapphiros Appoints Mark Gladwell as CEO and President

READ MORE

Sapphiros Acquires Flexotronix Limited

READ MORE

Mike Musgnug Joins Sapphiros as Executive Vice President, Strategy and CEO, GrapheneDx

READ MORE

Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies

READ MORE